Cannabidiol & Glucose Tolerance: Clinical Research Findings
This pilot study examined short-term low-dose cannabidiol supplementation and its effects on glucose tolerance. The findings showed no improvement in glucose tolerance or gut microbiome changes. Short-term low-dose cannabidiol use alone is unlikely to…
Cannabidiol & Glucose Tolerance: Clinical Research Review
This article reviews cannabidiol glucose tolerance clinical trial findings in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome with low-dose CBD. These findings highlight the…
Endocannabinoid System Clinical Research: CBD & Metabolic Health Insights
This pilot study examined cannabidiol glucose tolerance clinical trial evidence in sedentary adults with overweight or obesity. Results showed short-term low-dose CBD did not improve glucose tolerance or alter gut microbiome composition. These findings…